Michael C. Chen

机构：PureTech (United States), Temple University, University of Colorado Denver · ORCID：0000-0001-5178-4632

发表论文 95 篇 · 总被引 2885 次 · h-index 21

代表论文

• Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial (2021 · The Lancet · 被引 663)
• RNA G-quadruplex is resolved by repetitive and ATP-dependent mechanism of DHX36 (2019 · Nature Communications · 被引 81)
• Characteristics Associated With New Patient Appointment No-Shows at an Academic Ophthalmology Department in the United States (2021 · American Journal of Ophthalmology · 被引 27)
• Wet Lab–Based Cataract Surgery Training Curriculum for the PGY 2/PGY 3 Ophthalmology Resident (2018 · MedEdPORTAL · 被引 20)
• A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium‐Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic Diseases (2021 · Clinical Pharmacology in Drug Development · 被引 17)
• Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole (2019 · Cornea · 被引 16)